Stock NTCP NETCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Netcare Limited Johannesburg S.E.

Equities

NTCP

ZAE000081121

Healthcare Facilities & Services

End-of-day quote Johannesburg S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
77.71 ZAR 0.00% Intraday chart for Netcare Limited -0.37% -5.23%
May. 20 Transcript : Netcare Limited, H1 2024 Earnings Call, May 20, 2024
May. 20 Netcare Limited Declares Interim Cash Dividend for the Six Months Ended March 31, 2024, Payable on July 15, 2024 CI

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 23,597 17,357 21,636 18,344 17,968 15,085 - -
Enterprise Value (EV) 1 28,711 27,825 31,059 27,703 27,988 24,976 24,991 24,611
P/E ratio 10 x 46 x 29.8 x 19.1 x 14.4 x 9.64 x 8.32 x 7.19 x
Yield 6.32% - 2.1% 3.64% 4.81% 6.21% 7.54% 8.66%
Capitalization / Revenue 1.09 x 0.92 x 1.02 x 0.85 x 0.76 x 0.61 x 0.57 x 0.54 x
EV / Revenue 1.33 x 1.48 x 1.47 x 1.28 x 1.18 x 1 x 0.94 x 0.88 x
EV / EBITDA 6.54 x 10.9 x 9.57 x 7.95 x 7.01 x 5.48 x 5.06 x 4.63 x
EV / FCF -184 x -14.2 x 26.5 x 56.8 x 75 x 19.5 x 14.2 x 12.4 x
FCF Yield -0.54% -7.02% 3.78% 1.76% 1.33% 5.14% 7.05% 8.06%
Price to Book 2.47 x 1.89 x 2.18 x 1.79 x 1.6 x 1.26 x 1.23 x 1.19 x
Nbr of stocks (in thousands) 1,344,574 1,343,441 1,335,547 1,337,000 1,331,000 1,296,000 - -
Reference price 2 17.55 12.92 16.20 13.72 13.50 11.64 11.64 11.64
Announcement Date 11/18/19 11/23/20 11/22/21 11/21/22 11/21/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 21,589 18,843 21,200 21,636 23,699 24,907 26,654 28,120
EBITDA 1 4,388 2,558 3,244 3,485 3,990 4,558 4,937 5,315
EBIT 1 3,640 1,393 2,076 2,282 2,716 3,250 3,541 3,862
Operating Margin 16.86% 7.39% 9.79% 10.55% 11.46% 13.05% 13.29% 13.74%
Earnings before Tax (EBT) 1 3,357 730 1,176 1,534 1,807 2,259 2,621 3,010
Net income 1 2,447 446 769 1,013 1,321 1,567 1,853 2,121
Net margin 11.33% 2.37% 3.63% 4.68% 5.57% 6.29% 6.95% 7.54%
EPS 2 1.750 0.2810 0.5430 0.7170 0.9350 1.207 1.398 1.619
Free Cash Flow 1 -156 -1,953 1,173 488 373 1,283 1,763 1,983
FCF margin -0.72% -10.36% 5.53% 2.26% 1.57% 5.15% 6.61% 7.05%
FCF Conversion (EBITDA) - - 36.16% 14% 9.35% 28.14% 35.71% 37.3%
FCF Conversion (Net income) - - 152.54% 48.17% 28.24% 81.84% 95.16% 93.46%
Dividend per Share 2 1.110 - 0.3400 0.5000 0.6500 0.7226 0.8781 1.008
Announcement Date 11/18/19 11/23/20 11/22/21 11/21/22 11/21/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1
Net sales 1 10,713 8,130 10,081 11,119 10,311 11,325 11,537 12,162 12,034
EBITDA 1 2,360 - - 1,751 - 1,860 2,015 - 2,167
EBIT 1 1,787 - - 1,161 - - - - 1,502
Operating Margin 16.68% - - 10.44% - - - - 12.48%
Earnings before Tax (EBT) 1 - - - - - - - - 989
Net income 1 583 - - - - - - - 677
Net margin 5.44% - - - - - - - 5.63%
EPS - - - - - 0.3980 - - -
Dividend per Share - - - - - 0.3000 - - -
Announcement Date 5/25/20 11/23/20 5/24/21 11/22/21 5/23/22 11/21/22 5/22/23 11/21/23 5/20/24
1ZAR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 5,114 10,468 9,423 9,359 10,020 9,890 9,906 9,526
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.165 x 4.092 x 2.905 x 2.686 x 2.511 x 2.17 x 2.006 x 1.792 x
Free Cash Flow 1 -156 -1,953 1,173 488 373 1,283 1,763 1,983
ROE (net income / shareholders' equity) 24.4% 3.35% 8.07% 11% 12.1% 13.7% 15.3% 16.8%
ROA (Net income/ Total Assets) 11.1% 1.32% - 3.9% 4.89% 5.52% 6.35% 7.27%
Assets 1 21,960 33,737 - 25,946 27,036 28,422 29,189 29,171
Book Value Per Share 2 7.090 6.830 7.430 7.660 8.440 9.260 9.490 9.750
Cash Flow per Share 2 0.9000 -0.7400 1.720 1.400 1.400 1.200 2.020 2.270
Capex 1 1,378 961 1,132 1,396 1,507 1,390 1,597 1,796
Capex / Sales 6.38% 5.1% 5.34% 6.45% 6.36% 5.58% 5.99% 6.39%
Announcement Date 11/18/19 11/23/20 11/22/21 11/21/22 11/21/23 - - -
1ZAR in Million2ZAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Netcare Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
11.64 ZAR
Average target price
14.95 ZAR
Spread / Average Target
+28.42%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+24.66% 88.38B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-21.76% 77.56B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+1.76% 26.97B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+7.94% 18.45B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-13.50% 16.57B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+3.23% 15.81B
NATERA, INC. Stock Natera, Inc.
+77.51% 13.65B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+76.96% 13.06B
UNIVERSAL HEALTH SERVICES, INC. Stock Universal Health Services, Inc.
+23.02% 12.55B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. NTC Stock
  4. NTCP Stock
  5. Financials Netcare Limited